Hercules Pharmaceuticals today announced the appointment of Ali Ahmed as Executive Vice President, Chief Commercial Officer.

First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework ...

The program is designed with a novel, liver-detargeting, muscle-tropic capsid intended to improve safety and ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that ...

Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...

Manifold Bio, a platform therapeutics company pioneering AI-guided drug discovery coupled with massively multiplexed in vivo ...

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026FORT ...

FutureWise Research, a leading provider of strategic market intelligence, has published an in-depth new market analysis ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of ...

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disordersGenSci to receive $70 million ...

The "Botulinum Toxin in Urology Market Outlook 2026-2034: Market Share and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Botulinum Toxin in Urology Market is valued at USD 1 ...

John Johnson, current board member, appointed to chairman of the boardMichael Kauffman, M.D., Ph.D., lead director since 2016, appointed to president of developmentCommercial launch progresses as RAMP ...